PharmaShots | Incisive News in 3 Shots

Subscribe Now

Post-Hoc Analysis

Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar- ranibizumab) for the Treatment of nAMD

Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar- ranibizumab) for the Treatment of nA...

September 10, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us